Israel - English - Ministry of Health

dexcel ltd, israel - tobramycin - solution for inhalation - tobramycin 300 mg / 5 ml - tobramycin - tobramycin - tobi is indicated for the management of pulmonary pseudomonas aeruginosa infection in cystic fibrosis (cf) patients age 6 years or older.

Israel - English - Ministry of Health

dexcel ltd, israel - tobramycin - inhalation powder hard capsules - tobramycin 28 mg - tobramycin - tobramycin - suppressive therapy of chronic pulmonary infection due to pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis.

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - tobramycin - nebuliser solution - 300 mg/5ml - other aminoglycosides

European Union - English - EMA (European Medicines Agency)

viatris healthcare limited - tobramycin - cystic fibrosis; respiratory tract infections - antibacterials for systemic use, - tobi podhaler is indicated for the suppressive therapy of chronic pulmonary infection due to pseudomonas aeruginosa in adults and children aged 6 years and older with cystic fibrosis. see sections 4.4 and 5.1 regarding data in different age groups.consideration should be given to official guidance on the appropriate use of antibacterial agents.

European Union - English - EMA (European Medicines Agency)

pari pharma gmbh - tobramycin - cystic fibrosis; respiratory tract infections - antibacterials for systemic use, , aminoglycoside antibacterials - vantobra is indicated for the management of chronic pulmonary infection due to pseudomonas aeruginosa in patients aged 6 years and older with cystic fibrosis (cf).consideration should be given to official guidance on the appropriate use of antibacterial agents.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - tobramycin - nebuliser liquid - 60mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

chiesi ltd - tobramycin - nebuliser liquid - 75mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pari medical ltd - tobramycin - nebuliser liquid - 100mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharmaceutical industries europe b.v. - tobramycin - nebuliser liquid - 60mg/1ml

European Union - English - EMA (European Medicines Agency)

pari pharma gmbh - tobramycin - respiratory tract infections; cystic fibrosis - antibacterials for systemic use, - vantobra is indicated for the management of chronic pulmonary infection due to pseudomonas aeruginosa in patients aged 6 years and older with cystic fibrosis (cf).consideration should be given to official guidance on the appropriate use of antibacterial agents.